Результаты поиска

Hematopoietic Tumors

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Monoclonal gammopathy of renal significance (MGRS): retrospective monocentric analysis of clinical outcomes and treatment strategies.

Monoclonal Gammopathy of Renal Significance (MGRS) is a group of rare disorders in which monoclonal proteins cause kidney damage. Due to its rarity, ongoing research is vital to refine diagnostics, enhance treatment, and improve outcomes. This retrospective study analyzed 34 patients with renal biopsy-proven MGRS-defining lesions. Patients were divided into two subgroups: kidney-limited AL amyloidosis (MGRS-A, 44%, n = 15) and other MGRS (MGRS-NA, 56%, n = 19). Key outcomes included progression-free survival and overall survival. Baseline characteristics such as histopathology, plasma cell per

Health status and infections in patients with symptomatic primary and secondary immunoglobulin G (IgG) deficiencies receiving intravenous IgG replacement.

BackgroundThe effects of intravenous immunoglobulin G replacement on perceived health and infection susceptibility of patients suffering from immunoglobulin G (IgG) deficiencies should be evaluated in a prospective analysis.MethodsPatients with symptomatic primary or secondary IgG deficiencies were interviewed prior to the first IgG infusion (t0) and over the course of their treatment (t1 - t6). The respondents rated their current health using a 100 point scale (EQ-5D-5L), ranging from 0 ('worst imaginable health') to 100 ('best imaginable health'). The patients also provided information on th

Adverse Effects of Virus-Specific T-Cell Therapy: An Integrative Review.

Allogeneic hematopoietic stem cell transplant (HSCT) remains the mainstay in treating many hematologic malignancies. T-cell-depleted grafts designed to reduce graft-vs.-host disease (GVHD) may be complicated by severe viral infections that increase morbidity and mortality. Despite the use of antiviral pharmacologic therapy, challenges in controlling viral infections include drug resistance and/or side-effect intolerability. Virus-specific T-cell (VST) therapy is a promising targeted therapy for treating severe or drug-refractory viral infections after HSCT. An integrative review was conducted

Совпадение в полном тексте источника
… Cancer research 2016 76 6445 6451 27784742 10.1158/0008-5472.CAN-16-1311 26 Styczynski Jan van der Velden Walter Fox Christopher P Engelhard Dan de la Camara Rafael Cordonnier Catherine Ljungman Per Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients …

Short-term assessment of functional outcomes and quality of life after thoracic and lumbar spinal metastasis surgery.

BackgroundBecause of improvements in initial tumor identification and treatment, as well as longer life expectancies, more people are receiving diagnoses for spinal metastases.ObjectiveThe aim of this study was to assess early functional outcomes and quality of life (QOL) after surgical management of patients with spinal metastases.Patients and methodsIn this prospective cohort study, a total of 33 patients with thoracic and lumbar spine metastases who underwent surgical management between November 2021 and August 2023 were followed up for 1 year or until death. Oswestry Disability Index and t

Совпадение в полном тексте источника
… Patients with lymphoproliferative disorders (multiple myeloma and lymphoma) were also included due to their similar natural history. …

Management of Immunosuppression in Kidney Transplant Recipients Who Develop Malignancy.

The risk of cancer increases after transplantation. However, the consensus on immunosuppression (IS) adjustment after diagnosis of malignancy is lacking. Our study aims to assess the impact of IS adjustment on mortality of post-kidney transplant patients and allograft outcomes. We retrospectively reviewed the data in our center of 110 subjects. Our results showed IS dose adjustment was not statistically associated with mortality risk (HR 1.94, 95%CI 0.85-4.41, p = 0.12), and chemotherapy was the only factor that was significantly related to mortality (HR 2.3, 95%CI 1.21-4.35, p = 0.01). IS red

Совпадение в полном тексте источника
… Figure 3 Number of patients in each type of cancer; PTLD = Post-transplant Lymphoproliferative Disorders, GU = Genitourinary, GYN = gynecology, GI = gastrointestinal. Other cancers are head/neck, Kaposi sarcoma, other sarcoma, brain, and unknown origin. …

Management of Multiple Myeloma and Usage of Bortezomib: Perspective from India and Ukraine.

Novel treatment strategies have remarkably improved the multiple myeloma (MM) patients' survival, with associated increased costs. A joint panel meet of international experts from India and Ukraine was held in New Delhi on May 19, 2016 focusing on MM management, bortezomib role, unmet medical needs, and current challenges. The health-care system for oncology in India is majorly private vs. government-based in Ukraine. In India, electrophoresis, serum-free light chain assays, bone marrow tests, and X-rays are available modes of diagnosis. Despite of the numerous cancer centers and stem cell tra

Совпадение в полном тексте источника
… Costs of Treating Lymphoproliferative Disorders in Ukraine: a Pilot Evaluation (Special Issue). Medicinskie tehnologii. Ocenka i vybo-Медицинские технологии. Оценка и выбор (2012). p. 73–6. 30. Mandrik O, Zalis’ka O, Severens JL. PCN57 cost of treatment of multiple myeloma in Ukraine. …

The Applications of Machine Learning in the Management of Patients Undergoing Stem Cell Transplantation: Are We Ready?

Hematopoietic stem cell transplantation (HSCT) is a life-saving therapy for hematologic malignancies, such as leukemia and lymphoma and other severe conditions but is associated with significant risks, including graft versus host disease (GVHD), relapse, and treatment-related mortality. The increasing complexity of clinical, genomic, and biomarker data has spurred interest in machine learning (ML), which has emerged as a transformative tool to enhance decision-making and optimize outcomes in HSCT. This review examines the applications of ML in HSCT, focusing on donor selection, conditioning re

Unveiling the Complexities of Hereditary Angioedema.

Hereditary angioedema (HAE) is a rare and potentially life-threatening genetic disorder, constituting approximately 2% of all clinical cases of angioedema, with a global prevalence estimated between 1 in 50,000 and 1 in 150,000 individuals. The condition affects individuals of all genders and ethnic backgrounds without significant variation. HAE is classified into three types. Type I HAE, which accounts for 85% of cases, is characterized by a deficiency of the C1 esterase inhibitor (C1-INH) gene. Type II HAE, making up 15% of cases, involves a dysfunctional C1-INH. Type III HAE, which represen

Are neurological complications of monoclonal gammopathy of undetermined significance underestimated?

OBJECTIVES: Monoclonal gammopathy of undetermined significance (MGUS) is a premalignancy preceding multiple myeloma (MM) or related disorders. Neurological symptoms caused by the monoclonal immunoglobulins or free light-chains are often associated with a high morbidity. We analyzed the prevalence of neuropathy, clinical features and the long-term outcome in 223 patients (pts.) with MGUS. PATIENTS AND METHODS: Between 1/2005 and 3/2015, 223 adult pts. with MGUS were identified in our database. RESULTS: In36/223 pts. (16%) a neuropathy was diagnosed (MGUS associated neuropathy, MGUS-N). 20 pts

Changes in Hospitalization and Infection Burden in Patients with Multiple Myeloma Before and During the COVID-19 Pandemic

Background: The increasing incidence and improved survival rates of multiple myeloma (MM) have led to a growing healthcare burden, particularly in terms of hospitalizations. In addition, infection-related complications remain a major cause of morbidity and mortality in these patients. The impact of infection control measures implemented during the COVID-19 pandemic on hospitalization patterns in MM is not well-established. Methods: We conducted a retrospective observational study including all hospital admissions of patients with MM in a tertiary hospital in Spain across three different period

Совпадение в полном тексте источника
… Admissions corresponding to other hematologic diseases were also recorded and classified into the following categories: - Acute leukemia (AL); - Myelodysplastic syndromes and chronic myelomonocytic leukemia (MDS/CMML); - Chronic myeloproliferative neoplasms (MPNs); - Lymphoproliferative disorders (LPDs …

Long-acting granulocyte colony-stimulating factor in primary prophylaxis of early infection in patients with newly diagnosed multiple myeloma.

PurposeThis study sought to compare the efficacy of prophylactic long-acting and standard granulocyte colony-stimulating factor (G-CSF) on febrile neutropenia, early infections, and treatment delay in patients with newly diagnosed multiple myeloma (MM) receiving the therapeutic regimen of bortezomib, lenalidomide, and dexamethasone (VRd).MethodsA prospective study with 68 consecutive patients with MM was conducted in three regional hospitals. Participants were randomly treated with the VRd regimen in combination with prophylactic long-acting G-CSF (treatment group) or prophylactic standard G-C

Совпадение в полном тексте источника
… Aapro MS Bohlius J Cameron DA 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours Eur J Cancer 2011 47 1 8 32 10.1016/j.ejca.2010.10.013 …

A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic Malignancies.

T-replete haploidentical donor transplants using posttransplant cyclophosphamide (haplo) have greatly expanded donor availability and are increasingly utilized. Haplo were originally performed using truly nonmyeloablative conditioning and a bone marrow graft. We have also developed myeloablative conditioning and peripheral blood stem cell (PBSC) grafts for use with haplo. However, some patients may not tolerate myeloablative conditioning but may still benefit from a more dose-intensified preparative regimen to control malignancy and diminish graft rejection. To this end, we enrolled 25 patient

Development and 10-year history of a biosimilar: the example of Binocrit®.

Patent expirations for several biological products have prompted the development of alternative versions, termed 'biosimilars', which have comparable quality, safety and efficacy to a licensed biological medicine (also referred to as the 'reference' medicine). The first biosimilars developed in oncology were the supportive-care agents filgrastim and epoetin. Binocrit® (HX575) is a biosimilar version of epoetin alfa, indicated in the oncology setting for the treatment of chemotherapy-induced anemia (CIA). The process for development and approval of Binocrit® as a biosimilar included extensive a

Совпадение в полном тексте источника
… Treatment with Binocrit ® was well tolerated and allowed patients with non-Hodgkin lymphoma or chronic lymphoproliferative disorders to continue their course of chemotherapy by effectively increasing and maintaining Hb levels. 23 Binocrit ® treatment (for a minimum of 12 weeks) has also been evaluated …

Human herpes virus co-infection is associated with mortality in HIV-negative patients with Pneumocystis jirovecii pneumonia.

The purpose of this investigation was to characterize the management and prognosis of severe Pneumocystis jirovecii pneumonia (PJP) in human immunodeficiency virus (HIV)-negative patients. An observational cohort study of HIV-negative adults with PJP documented by bronchoalveolar lavage (BAL) through Gomori-Grocott staining or immunofluorescence, admitted to one intensive care unit (ICU) for acute respiratory failure, was undertaken. From 1990 to 2010, 70 patients (24 females, 46 males) were included, with a mean age of 58.6 ± 18.3 years. The mean Simplified Acute Physiology Score (SAPS)-II wa

Current trends of infectious complications following hematopoietic stem cell transplantation in a single center.

This study was to analyze the infectious complications after hematopoietic stem cell transplantation (HSCT) according to the recent changes of HSCT. Medical records of 379 adult patients who underwent HSCT consecutively at Catholic HSCT Center from January 2001 to December 2002 were reviewed retrospectively. Allogeneic HSCT accounted for 75.7% (287/379) and autologous HSCT for 24.3% (92/379). During pre-engraftment period, bacterial infection was predominant, and E. coli was still the most common organism. After engraftment, viral infection was predominant. The incidence of invasive fungal inf

Совпадение в полном тексте источника
… There was a case of meningoencephalitis caused by HHV-6 and 2 cases of EBV-associated posttransplant lymphoproliferative disorders (PTLD). …

Abnormalities in alternative splicing of angiogenesis-related genes and their role in HIV-related cancers.

Alternative splicing of mRNA leads to an increase in proteome biodiversity by allowing the generation of multiple mRNAs, coding for multiple protein isoforms of various structural and functional properties from a single primary pre-mRNA transcript. The protein isoforms produced are tightly regulated in normal development but are mostly deregulated in various cancers. In HIV-infected individuals with AIDS, there is an increase in aberrant alternative splicing, resulting in an increase in HIV/AIDS-related cancers, such as Kaposi's sarcoma, non-Hodgkin's lymphoma, and cervical cancer. This aberra

Мандибулярная плазмоцитома как первоначальное проявление несекретарской множественной миеломы: Редкая диагностика.

Плазменные клеточные новообразования, связанные с челюстями, редки, при этом мантибулярное участие представляет собой редкое первоначальное проявление системной множественной миеломы (ММ). Их неспециальная клиническая и радиография часто имитирует более распространенные одонтогенные и подстрекательские условия, что затрудняет раннюю диагностику. Мы сообщаем о случае с 81-летним мужчиной, который испытывал боль и опухоль на левой задней челюсти в течение двух месяцев. Клиническое обследование выявило диффузный отек левого челюсти и угла. Ортопантомография (ОПГ) продемонстрировала четко определе

Совпадение в полном тексте источника
… Introduction Plasma cell neoplasms are a heterogeneous group of lymphoproliferative disorders characterized by the clonal proliferation of terminally differentiated B lymphocytes (plasma cells). …

Борьба с травматической деформацией подбородка на чехле в недавно диагностированном миеломе: пример.

Обычно фонопатенты с множественной миеломой (ММ) управляются многодисциплинарными командами по онкологии в соответствии с неврологической, онкологической, механической и систематической системой принятия решений. Хирургия указывается на механическую нестабильность и/или неврологические недостатки. В неврологических и механически стабильных пациентах химиотерапия и радиотерапия часто являются основным лечением. 66-year-old Пациент мужского пола получил кифотическое повреждение подбородка на чехле из-за недиагностированной спинной мышцы ММ. Он испытывал постепенную боль в шее и трудности в повсе

Value of influenza vaccines in cancer patients during the coronavirus (COVID-19) pandemic: a cross-sectional study.

BackgroundAccording to the recommendation of the Centers for Disease Control and Prevention (CDC), getting influenza vaccines during the coronavirus (COVID-19) pandemics is especially important for people with certain underlying medical conditions, like cancer. Due to the similarities between the symptoms of influenza and COVID-19, receiving the flu vaccine in suspicious cases can be helpful because it will make it easier to request a medical test and diagnosis. In this study, the value of influenza vaccination in the cancer population was investigated.MethodsIn a cross-sectional study, all ca

Совпадение в полном тексте источника
… Influenza vaccine in chronic lymphoproliferative disorders and multiple myeloma. Eur J Haematol. 2003;70(4):225–230. doi: 10.1034/j.1600-0609.2003.00028.x. 7. Andersen MA, Niemann CU. Immune failure, infection and survival in chronic lymphocytic leukemia in Denmark. …